# KFF Type: Company Source: GetYourBrief — https://getyourbrief.com/entity/kff-company Canonical HTML page: https://getyourbrief.com/entity/kff-company ## Timeline - **2026-08-16**: NPR publishes report — A.W. describes her family's uncertainty after losing employer coverage. - **2026-08-11**: Rule finalized — The administration finalizes the funding restriction. - **2026-06**: HHS fraud report released — The Department of Health and Human Services publishes a report claiming 5.6 million fraudulent ACA enrollments in 2025 and asserts that 2.9 million were removed. - **2026**: Enrollment drops by nearly 3 million — Total ACA enrollment falls to about 19.2 million, a decline of nearly 3 million from the prior year, driven by steep premium increases and subsidy expiration. - **2025-12**: Rule proposed — The Trump administration proposes blocking federal Medicaid and CHIP funds for gender-affirming care for minors. - **2025-08**: Year-round low-income enrollment halted — The Trump administration ended a Biden-era initiative that allowed low-income people to sign up for ACA coverage year-round, part of efforts to tighten enrollment processes. - **2025**: 1.5 million removed for tax/Medicaid issues — Regulators removed approximately 1.5 million individuals from ACA rolls for reasons such as not filing taxes or being concurrently enrolled in Medicaid. ## Recent coverage (9 stories, network-wide) ### 130,000 trans youth face unprecedented Medicaid funding ban 2026-08-16 18:16:23 · Sector: legal · Sentiment: Neutral · Impact: 5/10 · Sources: 2 The finalized rule conditioning federal Medicaid and CHIP dollars on excluding pediatric gender-affirming care creates a novel federal funding restriction that legal experts say has no direct precedent. Attorneys and health policy counsel are already assessing potential Administrative Procedure Act, equal protection, and Medicaid Act challenges. Full story: https://getlegalbrief.com/story/medicaid-gender-affirming-care-funding-ban-legal ### 130,000 trans youth in Medicaid face loss of gender-affirming care 2026-08-16 18:16:14 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2 A finalized federal rule prohibits Medicaid and CHIP from covering gender-affirming care for 130,000 transgender minors living in states where it remains legal. Clinicians, health systems, and Medicaid plans must now manage coverage denials, care disruptions, and mental health risks for an already vulnerable pediatric population. Full story: https://gethealthbrief.com/story/medicaid-gender-affirming-care-trans-youth-health-impact ### Prior Auth Denials Hit 12–18% Across Public Plans; 67% Overturned in MA 2026-08-14 17:41:13 · Sector: health · Sentiment: Negative · Impact: 6/10 · Sources: 2 KFF's first analysis of mandatory 2026 prior authorization reporting reveals wide variation in denial rates across Medicare Advantage, Medicaid, and ACA Marketplace plans, with 12%-18% of standard requests denied and most appealed denials overturned. For healthcare leaders, the data expose care access barriers and administrative friction that vary sharply by insurer. Full story: https://gethealthbrief.com/story/health-prior-auth-denials-kff-2026 ### UNH Prior-Auth Denials at 17%, Centene 25%: New KFF Transparency Data 2026-08-14 17:40:58 · Sector: finance · Sentiment: Negative · Impact: 6/10 · Sources: 2 New federal transparency data provides the first comparable prior authorization denial rates for public plan insurers. Outliers UnitedHealth at 17% in Medicare Advantage and Centene at 25% in ACA Marketplace face reputation and regulatory risk, while low-denial plans may gain a competitive edge. Full story: https://getfinancebrief.com/story/finance-insurer-prior-auth-denials-kff-2026 ### 3M People Drop Obamacare as Premiums Surge 58% – Insurer Risk Up 2026-08-05 01:35:58 · Sector: finance · Sentiment: Neutral · Impact: 6/10 · Sources: 3 The exodus of nearly 3 million ACA enrollees, driven by a 58% premium increase, raises concerns about the stability of the individual health insurance market and the profitability of insurers exposed to it. Full story: https://getfinancebrief.com/story/obamacare-enrollment-drop-insurer-risk ### 58% Premium Spike and $3,800 Deductibles Push 3M Off ACA Plans 2026-08-05 01:34:21 · Sector: health · Sentiment: Neutral · Impact: 6/10 · Sources: 3 Steep premium and deductible increases have driven nearly 3 million Americans off ACA marketplace coverage, even as the Trump administration blames fraud. The erosion of affordability threatens to reverse historic gains in insurance coverage. Full story: https://gethealthbrief.com/story/obamacare-enrollment-drop-health-cost-crisis ### 2.9M Removed: HHS Fraud Claim vs. 58% Premium Hike Spurs Legal Debate 2026-08-05 01:33:12 · Sector: legal · Sentiment: Neutral · Impact: 6/10 · Sources: 3 The Trump administration insists a crackdown on fraud removed 2.9 million from ACA rolls, but legal experts question the legitimacy of the politically crafted HHS report and the procedures used to disenroll millions without clear evidence. Full story: https://getlegalbrief.com/story/obamacare-enrollment-drop-fraud-legal-scrutiny ### Insurers Face $3.6B Subsidy Loss as Trump Ends Medicare Part D Support 2026-07-29 18:17:15 · Sector: finance · Sentiment: Negative · Impact: 7/10 · Sources: 2 The removal of a $3.6 billion annual federal subsidy for Medicare Part D plans creates immediate earnings uncertainty for major health insurers, with rate increases expected and potential adverse selection threatening margins. Full story: https://getfinancebrief.com/story/insurers-face-3-6b-medicare-part-d-subsidy-loss ### Medicare Part D Subsidy Cut: Drugmakers Face $3.6B Shift in Patient Access 2026-07-29 18:16:37 · Sector: bio · Sentiment: Negative · Impact: 7/10 · Sources: 2 The termination of the $3.6 billion Part D premium subsidy could alter prescription utilization patterns for 25 million Medicare beneficiaries, potentially reducing demand for branded drugs and pressuring pharma companies reliant on Part D volume. Full story: https://getbiobrief.com/story/medicare-part-d-subsidy-cut-drugmaker-access --- This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.